Accessibility: Skip TopNav
1002-046 (Study 3) Phase 3 Efficacy Study – Safety & Tolerability
Overview of Adverse Events
Format
PNG
Source
Esperion Therapeutics, Inc.
Downloads
Original
Large
Medium
Small